Becton, Dickinson and Company Stock

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:02 2024-06-24 EDT 5-day change 1st Jan Change
235.9 USD -1.00% Intraday chart for Becton, Dickinson and Company +1.36% -3.25%
Sales 2024 * 20.25B 27.66B Sales 2025 * 21.42B 29.25B Capitalization 68.18B 93.12B
Net income 2024 * 2.09B 2.86B Net income 2025 * 2.48B 3.39B EV / Sales 2024 * 4.02 x
Net Debt 2024 * 13.13B 17.93B Net Debt 2025 * 10.8B 14.74B EV / Sales 2025 * 3.69 x
P/E ratio 2024 *
33.1 x
P/E ratio 2025 *
29.3 x
Employees 73,000
Yield 2024 *
1.59%
Yield 2025 *
1.63%
Free-Float 77.74%
More Fundamentals * Assessed data
Dynamic Chart
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024 CI
Evercore ISI Raises Becton, Dickinson and Company's Price Target to $290 From $282 MT
Sector Update: Health Care Stocks Steady Premarket Monday MT
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash DJ
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion MT
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion. CI
DBS Bank Adjusts Price Target on Becton, Dickinson to $285 From $300 MT
Transcript : Becton, Dickinson and Company Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM
Exclusive-Biden to put tariffs on China medical supplies - sources RE
Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating MT
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271 MT
Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280 MT
Sector Update: Health Care Stocks Mixed Premarket Thursday MT
More news
1 day-1.00%
1 week+1.36%
Current month+1.70%
1 month+3.11%
3 months-4.20%
6 months-2.92%
Current year-3.25%
More quotes
1 week
232.08
Extreme 232.08
239.58
1 month
224.00
Extreme 224
243.22
Current year
224.00
Extreme 224
249.89
1 year
224.00
Extreme 224
287.32
3 years
215.90
Extreme 215.9
287.32
5 years
197.75
Extreme 197.75
287.32
10 years
112.15
Extreme 112.15
287.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 08-12-31
Director of Finance/CFO 52 21-09-05
Chief Tech/Sci/R&D Officer 48 18-12-31
Members of the board TitleAgeSince
Director/Board Member 73 02-09-23
Director/Board Member 73 13-01-28
Director/Board Member 69 10-07-25
More insiders
Date Price Change Volume
24-06-24 235.9 -1.00% 895,747
24-06-21 238.3 -0.05% 2,014,700
24-06-20 238.4 +2.00% 1,655,716
24-06-18 233.7 +0.42% 1,035,778

Delayed Quote Nyse, June 24, 2024 at 04:00 pm

More quotes
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
235.9 USD
Average target price
279.2 USD
Spread / Average Target
+18.34%
Consensus